Articles published by Amylyx Pharmaceuticals, Inc.
![](https://mms.businesswire.com/media/20220706005028/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220704005425/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220531006018/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220602006037/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220526005131/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220506005325/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220512005325/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Via Business Wire
Tickers
AMLX
![](https://mms.businesswire.com/media/20220505005723/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220402005033/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220330005922/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Via Business Wire
Tickers
AMLX
![](https://mms.businesswire.com/media/20220330005921/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220330005162/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220328005619/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220318005225/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Via Business Wire
Tickers
AMLX
![](https://mms.businesswire.com/media/20220224005861/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220223005452/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220216006084/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220210005251/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Amylyx Pharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference
February 10, 2022
Via Business Wire
Tickers
AMLX
![](https://mms.businesswire.com/media/20220106005955/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220104005424/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20220103005147/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Amylyx Pharmaceuticals Announces Launch of Initial Public Offering
January 03, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20211229005058/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20211109005664/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20211104005663/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20211102005320/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20211026005775/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20210915005297/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20210913005206/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
![](https://mms.businesswire.com/media/20210831005553/en/802420/5/13268_Amylyx_logo_notagline-Color.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.